Wedge Capital Management L L P NC Purchases 14,468 Shares of HCA Healthcare, Inc. $HCA

Wedge Capital Management L L P NC raised its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 21.7% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 81,008 shares of the company’s stock after buying an additional 14,468 shares during the period. Wedge Capital Management L L P NC’s holdings in HCA Healthcare were worth $31,584,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Sumitomo Life Insurance Co. grew its holdings in shares of HCA Healthcare by 1.0% during the 4th quarter. Sumitomo Life Insurance Co. now owns 2,026 shares of the company’s stock worth $946,000 after acquiring an additional 20 shares during the period. MJP Associates Inc. ADV grew its stake in HCA Healthcare by 2.9% in the fourth quarter. MJP Associates Inc. ADV now owns 749 shares of the company’s stock worth $350,000 after purchasing an additional 21 shares during the period. Cary Street Partners Investment Advisory LLC lifted its position in HCA Healthcare by 7.5% during the fourth quarter. Cary Street Partners Investment Advisory LLC now owns 300 shares of the company’s stock valued at $140,000 after buying an additional 21 shares during the period. Anchyra Partners LLC grew its position in shares of HCA Healthcare by 3.7% in the 1st quarter. Anchyra Partners LLC now owns 587 shares of the company’s stock worth $278,000 after buying an additional 21 shares during the period. Finally, Plato Investment Management Ltd lifted its position in HCA Healthcare by 0.6% during the 4th quarter. Plato Investment Management Ltd now owns 3,908 shares of the company’s stock valued at $1,833,000 after acquiring an additional 22 shares during the period. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Trading Down 0.6%

HCA Healthcare stock opened at $411.55 on Wednesday. The firm has a market cap of $89.10 billion, a price-to-earnings ratio of 13.78, a PEG ratio of 1.44 and a beta of 1.10. HCA Healthcare, Inc. has a 12 month low of $353.99 and a 12 month high of $556.52. The stock has a fifty day simple moving average of $390.75 and a two-hundred day simple moving average of $447.87.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, July 24th. The company reported $7.59 EPS for the quarter, topping the consensus estimate of $7.56 by $0.03. The company had revenue of $20.23 billion during the quarter, compared to the consensus estimate of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.HCA Healthcare’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same period last year, the company earned $6.84 EPS. On average, equities research analysts forecast that HCA Healthcare, Inc. will post 29.45 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th will be given a $0.78 dividend. The ex-dividend date is Wednesday, September 16th. This represents a $3.12 annualized dividend and a yield of 0.8%. HCA Healthcare’s dividend payout ratio (DPR) is currently 10.45%.

Analyst Ratings Changes

A number of equities analysts have weighed in on the stock. Royal Bank Of Canada reaffirmed an “outperform” rating and set a $435.00 target price on shares of HCA Healthcare in a research note on Monday, July 27th. Raymond James Financial set a $528.00 price objective on HCA Healthcare in a research report on Tuesday, July 7th. Argus cut their target price on HCA Healthcare from $560.00 to $500.00 and set a “buy” rating on the stock in a research note on Monday, May 4th. Mizuho lowered their price target on HCA Healthcare from $525.00 to $475.00 and set an “outperform” rating for the company in a research report on Tuesday, July 28th. Finally, Robert W. Baird reduced their price objective on shares of HCA Healthcare from $396.00 to $393.00 and set a “neutral” rating for the company in a research note on Monday, July 27th. Fourteen equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $465.59.

HCA Healthcare News Roundup

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Zacks Research modestly increased its HCA EPS estimate for the second quarter of fiscal 2027 to $7.97 from $7.89. However, this isolated increase was outweighed by broader estimate reductions.
• Positive Sentiment: HCA’s former CFO discussed the potential role of partnerships in healthcare, which could support strategic growth and operating efficiency over time. HCA Healthcare’s former CFO on the role of partnerships in health
• Neutral Sentiment: A Tennessee HCA hospital appointed a new chief executive. The leadership change may affect local operations but does not appear to materially alter the broader investment outlook. HCA Tennessee hospital taps CEO
• Negative Sentiment: Zacks reduced its FY2026 EPS estimate to $29.40, nearly matching the $29.45 consensus, and cut its FY2027 forecast to $31.27 from $32.32. Its FY2028 estimate fell to $34.24 from $36.61.
• Negative Sentiment: Several quarterly forecasts were also lowered, including Q3 2026 EPS to $6.79 from $7.23, Q4 2026 to $7.87 from $8.17, Q1 2027 to $7.48 from $7.60, Q3 2027 to $7.20 from $7.74, Q4 2027 to $8.61 from $9.09, and Q1 2028 to $7.87 from $8.25. The pattern implies softer anticipated earnings momentum.
• Negative Sentiment: HCA workers are pushing for higher pay and increased staffing, creating potential labor-cost, retention and reputational risks. Such pressure could weigh on margins if the company makes meaningful compensation or staffing concessions. HCA workers push for higher pay and more staffing amid billions in profits

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.